Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Bioadaptives (BDPT) over the last 5 years, with Q3 2025 value amounting to $15500.0.

  • Bioadaptives' Non-Current Assets changed N/A to $15500.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $32500.0, marking a year-over-year decrease of 281.39%. This contributed to the annual value of $15441.0 for FY2023, which is 41642.14% up from last year.
  • Bioadaptives' Non-Current Assets amounted to $15500.0 in Q3 2025.
  • Over the past 5 years, Bioadaptives' Non-Current Assets peaked at $166625.0 during Q3 2023, and registered a low of $1644.0 during Q2 2023.
  • For the 5-year period, Bioadaptives' Non-Current Assets averaged around $38309.1, with its median value being $17000.0 (2025).
  • As far as peak fluctuations go, Bioadaptives' Non-Current Assets tumbled by 9637.73% in 2022, and later skyrocketed by 443524.77% in 2023.
  • Over the past 5 years, Bioadaptives' Non-Current Assets (Quarter) stood at $59709.0 in 2021, then tumbled by 94.99% to $2990.0 in 2022, then skyrocketed by 416.42% to $15441.0 in 2023, then rose by 16.57% to $18000.0 in 2024, then dropped by 13.89% to $15500.0 in 2025.
  • Its Non-Current Assets stands at $15500.0 for Q3 2025, versus $17000.0 for Q2 2025 and $18000.0 for Q1 2024.